Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Università del Piemonte Orientale Home
Italiano
English
Cerca contenuto all’indirizzo Università del Piemonte Orientale
Home
Profili
Unità di ricerca
Apparecchiatura
Progetti
Risultato della ricerca
Future perspectives in the medical treatment of endometriosis
Simone Ferrero
, Luiza Helena Abbamonte
, Paola Anserini
,
Valentino Remorgida
, Nicola Ragni
Risultato della ricerca
:
Contributo su rivista
›
Articolo di review
›
peer review
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'Future perspectives in the medical treatment of endometriosis'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Keyphrases
Medical Treatment
100%
Endometriosis
100%
Endometriosis Surgery
100%
Immune System
28%
Endometrial Lesions
28%
Nonsteroidal Aromatase Inhibitors
28%
Inflammation
14%
Clinical Trials
14%
Angiogenesis
14%
Clinical Data
14%
Clinical Application
14%
Drug Use
14%
Surgical Treatment
14%
Treatment Strategy
14%
Treatment Options
14%
Blockage
14%
New Drugs
14%
New Therapies
14%
Pain Intensity
14%
Family Physicians
14%
Aromatase Inhibitors
14%
Hormonal Treatment
14%
Third Generation
14%
Novel Therapeutics
14%
TNF Inhibitors
14%
Matrix Metalloproteinase Activity
14%
Pharmaceutical Agents
14%
Pain Symptoms
14%
Letrozole
14%
Learning Objectives
14%
Anastrozole
14%
Aromatase Activity
14%
Selective Progesterone Receptor Modulator
14%
Opportunity to Use
14%
Physician Learning
14%
Obstetrician-gynecologists
14%
Endometriosis Pathogenesis
14%
Therapeutic Manipulation
14%
Medicine and Dentistry
Combination Therapy
100%
Endometriosis
100%
Aromatase Inhibitor
25%
Immune System
16%
Clinical Trial
8%
Angiogenesis
8%
Clinical Study
8%
Recurrent Disease
8%
Pain (Symptom)
8%
Matrix Metalloproteinase
8%
Aromatase
8%
Letrozole
8%
Anastrozole
8%
Progesterone Receptor Modulator
8%
Diseases
8%
Nursing and Health Professions
Combination Therapy
100%
Endometriosis
100%
Aromatase Inhibitor
25%
Recurrent Disease
8%
Inflammation
8%
General Practitioner
8%
Matrix Metalloproteinase
8%
Gynecologist
8%
Aromatase
8%
Letrozole
8%
Progesterone Receptor Modulator
8%
Anastrozole
8%
Obstetrician
8%
Diseases
8%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Endometriosis
100%
Aromatase Inhibitor
25%
Clinical Trial
8%
Clinical Study
8%
Recurrent Disease
8%
Inflammation
8%
Matrix Metalloproteinase
8%
Letrozole
8%
Anastrozole
8%
Aromatase
8%
Progesterone Receptor Modulator
8%
Diseases
8%